Molecular Profiling in Lung Cancer Patients

NCT00191308 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer
Carcinoma

Interventions

DRUG: pemetrexed
DRUG: cisplatin
PROCEDURE: Radical Non-Small Cell Lung Cancer (NSCLC) surgery

Sponsor

Eli Lilly and Company